185 related articles for article (PubMed ID: 24973222)
1. A coding IRAK2 protein variant compromises Toll-like receptor (TLR) signaling and is associated with colorectal cancer survival.
Wang H; Flannery SM; Dickhöfer S; Huhn S; George J; Kubarenko AV; Lascorz J; Bevier M; Willemsen J; Pichulik T; Schafmayer C; Binder M; Manoury B; Paludan SR; Alarcon-Riquelme M; Bowie AG; Försti A; Weber ANR
J Biol Chem; 2014 Aug; 289(33):23123-23131. PubMed ID: 24973222
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 receptor-associated kinase-2 genetic variant rs708035 increases NF-κB activity through promoting TRAF6 ubiquitination.
Zhang W; He T; Wang Q; Li X; Wei J; Hou X; Zhang B; Huang L; Wang L
J Biol Chem; 2014 May; 289(18):12507-19. PubMed ID: 24662294
[TBL] [Abstract][Full Text] [Related]
3. The extreme C-terminus of IRAK2 assures full TRAF6 ubiquitination and optimal TLR signaling.
Joshi H; Lunz B; Peters A; Zölch M; Berberich I; Berberich-Siebelt F
Mol Immunol; 2021 Jun; 134():172-182. PubMed ID: 33799071
[TBL] [Abstract][Full Text] [Related]
4. Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer.
Xu Y; Liu H; Liu S; Wang Y; Xie J; Stinchcombe TE; Su L; Zhang R; Christiani DC; Li W; Wei Q
Int J Cancer; 2018 Nov; 143(10):2400-2408. PubMed ID: 29978465
[TBL] [Abstract][Full Text] [Related]
5. Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2.
Kawagoe T; Sato S; Matsushita K; Kato H; Matsui K; Kumagai Y; Saitoh T; Kawai T; Takeuchi O; Akira S
Nat Immunol; 2008 Jun; 9(6):684-91. PubMed ID: 18438411
[TBL] [Abstract][Full Text] [Related]
6. A frequent hypofunctional IRAK2 variant is associated with reduced spontaneous hepatitis C virus clearance.
Wang H; El Maadidi S; Fischer J; Grabski E; Dickhöfer S; Klimosch S; Flannery SM; Filomena A; Wolz OO; Schneiderhan-Marra N; Löffler MW; Wiese M; Pichulik T; Müllhaupt B; Semela D; Dufour JF; Bochud PY; Bowie AG; Kalinke U; Berg T; Weber AN;
Hepatology; 2015 Nov; 62(5):1375-87. PubMed ID: 26250868
[TBL] [Abstract][Full Text] [Related]
7. Human interleukin-1 receptor-associated kinase-2 is essential for Toll-like receptor-mediated transcriptional and post-transcriptional regulation of tumor necrosis factor alpha.
Flannery SM; Keating SE; Szymak J; Bowie AG
J Biol Chem; 2011 Jul; 286(27):23688-97. PubMed ID: 21606490
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 1/Toll-like receptor-induced autophosphorylation activates interleukin 1 receptor-associated kinase 4 and controls cytokine induction in a cell type-specific manner.
Cushing L; Stochaj W; Siegel M; Czerwinski R; Dower K; Wright Q; Hirschfield M; Casanova JL; Picard C; Puel A; Lin LL; Rao VR
J Biol Chem; 2014 Apr; 289(15):10865-10875. PubMed ID: 24567333
[TBL] [Abstract][Full Text] [Related]
9. IRAK4 mediates colitis-induced tumorigenesis and chemoresistance in colorectal cancer.
Li Q; Chen Y; Zhang D; Grossman J; Li L; Khurana N; Jiang H; Grierson PM; Herndon J; DeNardo DG; Challen GA; Liu J; Ruzinova MB; Fields RC; Lim KH
JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31527315
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 receptor-associated kinase 2 is critical for lipopolysaccharide-mediated post-transcriptional control.
Wan Y; Xiao H; Affolter J; Kim TW; Bulek K; Chaudhuri S; Carlson D; Hamilton T; Mazumder B; Stark GR; Thomas J; Li X
J Biol Chem; 2009 Apr; 284(16):10367-75. PubMed ID: 19224918
[TBL] [Abstract][Full Text] [Related]
11. Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-kappaB activation.
Conze DB; Wu CJ; Thomas JA; Landstrom A; Ashwell JD
Mol Cell Biol; 2008 May; 28(10):3538-47. PubMed ID: 18347055
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a dual role in myddosome formation and Toll-like receptor signaling.
De Nardo D; Balka KR; Cardona Gloria Y; Rao VR; Latz E; Masters SL
J Biol Chem; 2018 Sep; 293(39):15195-15207. PubMed ID: 30076215
[TBL] [Abstract][Full Text] [Related]
13. IRAK-1-mediated negative regulation of Toll-like receptor signaling through proteasome-dependent downregulation of TRAF6.
Muroi M; Tanamoto K
Biochim Biophys Acta; 2012 Feb; 1823(2):255-63. PubMed ID: 22033459
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive RNAi-based screening of human and mouse TLR pathways identifies species-specific preferences in signaling protein use.
Sun J; Li N; Oh KS; Dutta B; Vayttaden SJ; Lin B; Ebert TS; De Nardo D; Davis J; Bagirzadeh R; Lounsbury NW; Pasare C; Latz E; Hornung V; Fraser ID
Sci Signal; 2016 Jan; 9(409):ra3. PubMed ID: 26732763
[TBL] [Abstract][Full Text] [Related]
15. IRAK-2 participates in multiple toll-like receptor signaling pathways to NFkappaB via activation of TRAF6 ubiquitination.
Keating SE; Maloney GM; Moran EM; Bowie AG
J Biol Chem; 2007 Nov; 282(46):33435-33443. PubMed ID: 17878161
[TBL] [Abstract][Full Text] [Related]
16. Clinical IRAK4 deficiency caused by homozygosity for the novel
Jia A; James E; Lu HY; Sharma M; Modi BP; Biggs CM; Hildebrand KJ; Chomyn A; Erdle S; Kular H; Turvey SE
Cold Spring Harb Mol Case Stud; 2020 Jun; 6(3):. PubMed ID: 32532880
[TBL] [Abstract][Full Text] [Related]
17. The murine IRAK2 gene encodes four alternatively spliced isoforms, two of which are inhibitory.
Hardy MP; O'Neill LA
J Biol Chem; 2004 Jun; 279(26):27699-708. PubMed ID: 15082713
[TBL] [Abstract][Full Text] [Related]
18. Identification of a Constitutively Active Mutant Mouse IRAK2 by Retroviral Expression Screening.
Liu Y; Yin W; Xu L; Zhang H; Liu Q; Yin W
Mol Biotechnol; 2018 Apr; 60(4):245-250. PubMed ID: 29468521
[TBL] [Abstract][Full Text] [Related]
19. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling.
Lin SC; Lo YC; Wu H
Nature; 2010 Jun; 465(7300):885-90. PubMed ID: 20485341
[TBL] [Abstract][Full Text] [Related]
20. Putative link between Polo-like kinases (PLKs) and Toll-like receptor (TLR) signaling in transformed and primary human immune cells.
El Maadidi S; Weber ANR; Motshwene P; Schüssler JM; Backes D; Dickhöfer S; Wang H; Liu X; Garcia MD; Taumer C; Soufi B; Wolz OO; Klimosch SN; Franz-Wachtel M; Macek B; Gay NJ
Sci Rep; 2019 Sep; 9(1):13168. PubMed ID: 31511529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
